PT1501534E - Formulacoes farmaceuticas - Google Patents
Formulacoes farmaceuticasInfo
- Publication number
- PT1501534E PT1501534E PT03727870T PT03727870T PT1501534E PT 1501534 E PT1501534 E PT 1501534E PT 03727870 T PT03727870 T PT 03727870T PT 03727870 T PT03727870 T PT 03727870T PT 1501534 E PT1501534 E PT 1501534E
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0210397.6A GB0210397D0 (en) | 2002-05-07 | 2002-05-07 | Pharmaceutical formulations |
PCT/IB2002/004036 WO2003094885A1 (en) | 2002-05-07 | 2002-09-20 | Sublingual pharmaceutical formulation of desmopressin |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1501534E true PT1501534E (pt) | 2006-09-29 |
Family
ID=29422105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03727870T PT1501534E (pt) | 2002-05-07 | 2003-05-07 | Formulacoes farmaceuticas |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP2006502972A (pt) |
AU (1) | AU2003233118B8 (pt) |
BR (1) | BR0309819A (pt) |
CA (1) | CA2484724C (pt) |
DE (2) | DE60307082D1 (pt) |
HR (1) | HRP20041152B1 (pt) |
NO (1) | NO335167B1 (pt) |
NZ (1) | NZ535861A (pt) |
PT (1) | PT1501534E (pt) |
WO (1) | WO2003094886A2 (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
JP4523265B2 (ja) * | 2002-11-13 | 2010-08-11 | 旭化成ファーマ株式会社 | 排尿障害治療用口腔内崩壊製剤 |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7094545B2 (en) | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
DK1500390T3 (da) | 2003-07-25 | 2005-09-19 | Ferring Bv | Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf |
EP1689419A4 (en) * | 2003-11-10 | 2009-01-14 | Reprise Biopharmaceutics Llc | PHARMACEUTICAL COMPOSITIONS WITH LOW DOSES OF DESMOPRESSIN |
EP1530967B1 (en) * | 2003-11-13 | 2006-05-03 | Ferring B.V. | Blister pack and solid dosage form comprising desmopressin |
CA2490601C (en) * | 2003-12-29 | 2006-05-02 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
US7018653B2 (en) | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
SI1550439T1 (sl) * | 2003-12-29 | 2006-08-31 | Ferring Bv | Postopek za pripravo trdne dozirne oblike dezmopresina |
GB0406048D0 (en) * | 2004-03-18 | 2004-04-21 | Ardana Bioscience Ltd | Drug formulations |
US7972621B2 (en) * | 2004-06-03 | 2011-07-05 | R.P. Scherer Technologies, Llc | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
WO2007098945A2 (en) * | 2006-03-02 | 2007-09-07 | Ferring International Center S.A. | Stable solid dosage form comprising desmopressin |
SE528446C2 (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
WO2009015037A2 (en) | 2007-07-21 | 2009-01-29 | Albany Molecular Research, Inc. | 5-pyridinone substituted indazoles |
RU2472539C2 (ru) | 2007-08-06 | 2013-01-20 | Аллерган, Инк. | Способы и устройства для доставки препарата десмопрессина |
EP2674417A3 (en) | 2007-11-21 | 2014-04-09 | Decode Genetics EHF | Biaryl PDE4 inhibitors for treating inflammation |
JP5501251B2 (ja) | 2008-01-11 | 2014-05-21 | アルバニー モレキュラー リサーチ, インコーポレイテッド | Mch拮抗薬としての(1−アジノン)置換ピリドインドール類 |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
LT3225249T (lt) * | 2008-05-21 | 2019-01-10 | Ferring B.V. | Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui |
WO2010059836A1 (en) | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
BRPI1007350B8 (pt) | 2009-01-26 | 2021-05-25 | Israel Institute For Biological Res | compostos espiro heterocíclicos bicíclicos |
TWI471127B (zh) | 2009-04-29 | 2015-02-01 | Intervet Int Bv | 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物 |
TWI468157B (zh) * | 2009-04-29 | 2015-01-11 | Intervet Int Bv | 形成錠劑的方法,進行該方法的系統及包含該錠劑的包裝物 |
KR101792696B1 (ko) | 2009-06-18 | 2017-11-02 | 알레간 인코포레이티드 | 안전한 데스모프레신 투여 |
SG177523A1 (en) | 2009-07-14 | 2012-02-28 | Albany Molecular Res Inc | 5-ht3 receptor modulators, methods of making, and use thereof |
US10548839B2 (en) | 2010-03-16 | 2020-02-04 | Wei Tian | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
JO3112B1 (ar) * | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
CN104606128B (zh) | 2010-03-29 | 2018-02-23 | 辉凌公司 | 一种快速溶解药物组合物 |
WO2012048333A1 (en) * | 2010-10-08 | 2012-04-12 | R.P. Scherer Technologies, Llc | Oral vaccine fast-dissolving dosage form using starch |
JP2011116764A (ja) * | 2011-02-08 | 2011-06-16 | Fine Seymour H | 低用量デスモプレシンを含有する医薬組成物 |
US9731018B2 (en) | 2011-09-16 | 2017-08-15 | Ferring B.V. | Fast dissolving pharmaceutical composition |
JP5928159B2 (ja) * | 2012-05-28 | 2016-06-01 | ニプロ株式会社 | 医薬組成物 |
TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
CN103993061B (zh) * | 2014-05-20 | 2018-03-23 | 海南美合泰生物科技有限公司 | 一种鱼胶原蛋白的生产方法 |
KR20150144209A (ko) * | 2014-06-16 | 2015-12-24 | 훼링 비.브이. | 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물 |
JP6341777B2 (ja) * | 2014-06-30 | 2018-06-13 | リプリーズ バイオファーマシューティクス,エルエルシー | 低用量デスモプレシンを含有する医薬組成物 |
BR112019010949A2 (pt) | 2017-01-11 | 2019-10-01 | Ferring Bv | composição farmacêutica de desintegração rápida |
DE102017104472A1 (de) * | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung |
JP2021518413A (ja) | 2018-03-20 | 2021-08-02 | アイカーン スクール オブ メディシン アット マウント サイナイ | キナーゼ阻害剤化合物及び組成物ならびに使用方法 |
AU2019419414A1 (en) | 2018-12-31 | 2023-04-06 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
AU653026B2 (en) * | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
JP3253127B2 (ja) * | 1991-06-07 | 2002-02-04 | 帝國製薬株式会社 | 生理活性ポリペプチド含有製剤 |
US5298256A (en) * | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
US5849322A (en) * | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
GB9901819D0 (en) * | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
WO2000044251A1 (en) * | 1999-01-27 | 2000-08-03 | Spenco Medical Corporation | Therapeutic magnetic insoles |
US6210699B1 (en) * | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
-
2003
- 2003-05-07 DE DE60307082A patent/DE60307082D1/de not_active Expired - Lifetime
- 2003-05-07 WO PCT/IB2003/002368 patent/WO2003094886A2/en active IP Right Grant
- 2003-05-07 PT PT03727870T patent/PT1501534E/pt unknown
- 2003-05-07 JP JP2004502972A patent/JP2006502972A/ja active Pending
- 2003-05-07 DE DE2003607082 patent/DE60307082T4/de not_active Expired - Lifetime
- 2003-05-07 BR BR0309819-2A patent/BR0309819A/pt not_active Application Discontinuation
- 2003-05-07 AU AU2003233118A patent/AU2003233118B8/en not_active Expired
- 2003-05-07 CA CA002484724A patent/CA2484724C/en not_active Expired - Lifetime
- 2003-05-07 NZ NZ535861A patent/NZ535861A/en not_active IP Right Cessation
-
2004
- 2004-12-03 HR HR20041152A patent/HRP20041152B1/xx not_active IP Right Cessation
- 2004-12-06 NO NO20045345A patent/NO335167B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HRP20041152A2 (en) | 2005-04-30 |
DE60307082T4 (de) | 2015-04-30 |
AU2003233118A1 (en) | 2003-11-11 |
NZ535861A (en) | 2006-11-30 |
NO20045345L (no) | 2005-02-07 |
CA2484724C (en) | 2007-01-16 |
HRP20041152B1 (en) | 2008-01-31 |
BR0309819A (pt) | 2005-03-01 |
WO2003094886A3 (en) | 2004-07-22 |
AU2003233118B2 (en) | 2006-10-26 |
WO2003094886A2 (en) | 2003-11-20 |
DE60307082T2 (de) | 2007-01-18 |
NO335167B1 (no) | 2014-10-06 |
AU2003233118B8 (en) | 2009-07-30 |
JP2006502972A (ja) | 2006-01-26 |
DE60307082D1 (de) | 2006-09-07 |
CA2484724A1 (en) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1501534E (pt) | Formulacoes farmaceuticas | |
NO20033556L (no) | Farmasöytiske formuleringer | |
NO20033384D0 (no) | Farmasöytisk formulering | |
DK3384931T3 (da) | Superfin formoterolformulering | |
DK1575618T3 (da) | Dispergerbare farmaceutiske kombinationer | |
GB0210397D0 (en) | Pharmaceutical formulations | |
FI20011478A (fi) | Farmaseuttinen koostumus | |
NO20033785L (no) | Farmasöytisk formulering | |
IS8309A (is) | Lyfjablöndur | |
NO20040125L (no) | Enterale formuleringer | |
PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
IS7715A (is) | Nýjar lyfjasamsetningar úr módafíníl | |
DK1587478T3 (da) | Farmaceutisk sammensætning | |
NO20035627D0 (no) | Farmasöytisk formulering | |
IS7051A (is) | Lyfjasamsetningar | |
DK1596870T3 (da) | Höjdosis-iblandronatformulering | |
GB0218930D0 (en) | Pharmaceutical formulations | |
FI20022128A0 (fi) | Farmaseuttinen koostumus | |
NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
NO20044164L (no) | Farmasoytiske sammensetninger | |
DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
SE0201660D0 (sv) | Pharmaceutical formulation | |
SE0200449D0 (sv) | Pharmaceutical formulation | |
NO20041236L (no) | Farmasoytisk formulering | |
ITMI20020926A1 (it) | Composizioni farmaceutiche riepitelizzanti |